Key statistics
On Friday, HUTCHMED (China) Ltd (HCM:NSQ) closed at 17.59, -18.19% below its 52-week high of 21.50, set on Oct 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.79 |
---|---|
High | 17.97 |
Low | 17.58 |
Bid | 17.27 |
Offer | 17.86 |
Previous close | 17.52 |
Average volume | 46.87k |
---|---|
Shares outstanding | 174.42m |
Free float | 88.83m |
P/E (TTM) | 81.05 |
Market cap | 2.95bn USD |
EPS (TTM) | 0.2162 USD |
Data delayed at least 15 minutes, as of Jul 18 2025 21:00 BST.
More ▼
- HUTCHMED to Announce 2025 Half-Year Results
- HUTCHMED to Announce 2025 Half-Year Financial Results
- Update on Joint Corporate Brokers in London
- Blocklisting Six Monthly Return
- China Approval based on Phase III SACHI Trial
- Total Voting Rights
- HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy
- Grant of Share Options and Awards under LTIP
- HUTCHMED and Innovent Announce NDA Acceptance
- HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
More ▼